Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Al/ML Data sets
new
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Pancreatic cancer vaccines eliminate disease in preclinical trials
CLEVELAND—Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society.
MSD receives FDA approval for Enflonsia to prevent respiratory syncytial virus (RSV)
MSD has received US Food and Drug Administration (FDA) approval for Enflonsia (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in...
Aytu BioPharma to commercialise Exxua for major depressive disorder in the US
Aytu BioPharma to commercialise Exxua for major depressive disorder in the US
Psilera Collaborates with Drug Development Leader Hesperos
Psilera Collaborates with Drug Development Leader Hesperos to Advance Preclinical Modeling of PSIL-006 for Frontotemporal Dementia
FDA approves YolTech’s YOLT-101 for familial hypercholesterolemia
FDA approves YolTech’s YOLT-101 for familial hypercholesterolemia
Jade Biosciences Presents JADE101
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
Eli Lilly and Camurus enter cardiometabolic health partnership worth up to $870m
Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic health.
Finerenone plus SGLT2 inhibitor reduces albuminuria more than either drug alone
Concurrent use of finerenone and empagliflozin reduced urine albumin-to-creatinine ratio for adults with CKD and type 2 diabetes.
RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals
During an FDA panel discussion, the US health secretary prioritised easier routes to market for curative therapies.
Ozempic linked to rare cases of serious eye disorder
Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may, in very rare cases, cause a serious eye condition that can lead to vision loss, the European Medicines Agency's sa...
AstraZeneca’s Calquence approved by EC for first-line chronic lymphocytic leukaemia use
An estimated 27,000 cases of the disease were diagnosed in the UK, France, Germany, Spain and Italy in 2024
Dyne Therapeutics to Present New Preclinical Data
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
1
2
3
4
5
6
7
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds